More rational and conservative surgical strategies for malignant melanoma using lymphatic mapping and sentinel node biopsy techniques

Current Opinion in Oncology

Volumn 8, Issue 2, 1996, Pages 152-158

  Reintgen, Douglas ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MONOPHENOL MONOOXYGENASE;

CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL TRIAL; ELECTIVE SURGERY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MELANOMA; MULTICENTER STUDY; OCCULT CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SKIN CANCER;

EID: 0029886945     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199603000-00013     Document Type: Review

References (23)

1. Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern JJ, Murad TM, McCarthy WH, Maddox WA: A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage 1) melanoma treated in Alabama, USA and New South Wales, Australia. Ann Surg 1982, 196:677-684.
2. Reinigen DS, Cox EB, McCarty KS, Vollmer R, Seigler HF: Efficacy of elective lymph node dissection in patients with intermediate thickness melanoma. Ann Surg 1983, 198:379-385.
3. Milton GW, Shaw HM, McCarthy WH, Pearson L, Balch CM, Soong SJ: Prophylactic lymph node dissection in clinical stage 1 cutaneous malignant melanoma: results of surgical treatment in 1,319 patients. Br J Surg 1982, 69:108-111.
4. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA: A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1991, 193:77-85.
5. Ross MI: The case for elective lymphadenectomy. Surg Oncol Clin North Am 1992, 1:205-222.
6. Stankard C, Cruse CW, Cox C, Wells K, King J, Reinigen DS: The concept of lymph node dissections in patients with malignant melanoma. Ann Plast Surg 1992, 28:33-38.
7. Ross M, Reintgen DS, Balch C: Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993, 9:219-223
8. Crowley NJ: The case against elective lymphadenectomy. Surg Oncol Clin North Am 1992, 1:223-246.
9. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH: A prospective randomized study of the efficacy of routine elective lymphadenectomy in the management of malignant melanoma: preliminary results. Cancer 1978, 41:948-956.
10. Veronesi U, Adamus J, Bandiera DC, Brennhova IO, Cuceves E, Cascarelli N, Claudio F, Ikonopisuv RL, Javovski W, Kirov S, et al.: Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977, 297:627-630.
11. Norman J, Cruse CW, Espinosa C, Cox C, Berman CG, Clark R, Saba H, Wells K, Reintgen DS: Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg 1991, 162:432-437.
12. Reintgen DS, Albertini J, Berman C, Cruse CW, Fenske N, Glass F, Puleo C, Wang X, Wells K, Rapaport D, et al.: Accurate nodal staging of malignant melanoma. Cancer Control J Moffitt Cancer Center 1995, 2:405-414.
13. Godellas CV, Berman C, Lyman G, Cruse CW, Rapapport D, Heller R, Wang X, Glass F, Fenske N, Messina J, et al.: The Identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg 1995, 61:97-101.
14. Wong JH, Cagle LA, Morton DL: Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 1991, 214:637-641.
15. Wong JH, Economou JS, Cagle LA, Storm FS, Foshag LJ, Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-399.
16. Morton DL, Wen DR, Cochran AJ: Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine lymphadenectomy or "watch and wait." Surg Oncol Clin North Am 1992, 1:247-259.
17. Reintgen DS, Cruse CW, Berman C, Ross M, Rappaport D, Glass F, Fenske N, Messina J: An orderly progression of melanoma nodal metastases. Ann Surg 1994, 220:759-767. This trial shows that melanoma nodal metastases are not random events, but rather there is order to the spread of disease to the regional nodes. The authors provide a compelling statistical argument that the SLN is a special node and can reliably determine whether occult metastases are present within the regional basin. This confirms the initial observation of Morton's group (Morton et al., Surg Oncol Clin North Am 1992, 1:247-259) and demonstrates continued enthusiasm for this surgical technique.
18. Albertini J, Cruse CW, Rapaport D, Wells K, Russ M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, et al.: Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification in melanoma patients. Ann Surg 1996, 223:217-224. The addition of radiocolloid mapping with the Neoprobe (Neoprobe Corporation, Dublin, OH) makes the SLN mapping technique easier, allowing for more conservative surgery and a wider applicability in the surgical community.
19. Miliotes G, Albertini J, Berman C, Messina J, Glass F, Cruse CW, Rapapport D, Puelo C, Fenske N, Petsuglon C, et al.: The tumor biology of melanoma nodal metastases. Am Surg 1996, in press.
20. Wang X, Cruse CW, Berman C, Fenske N, Glass F, Messina J, Heller R, Puleo C, Reinigen DS: The Identification of submicroscopic lymph node metastases in patients with malignant melanoma. Ann Surg 1994, 220:768-774. The sensitivity of the standard methods for pathological evaluation of lymph nodes have long been questioned. The authors described a provocative test using RT-PCR assays for the messenger RNA for the tyrosinase gene. These so-called "submicroscopic" lymph node metastases can be identified in 36% of the histologic node negative melanoma population. Long-term clinical follow-up is necessary to prove clinical correlation.
21. Reintgen DS, Einstein A: The role of research in cost containment Cancer Control J Moffitt Cancer Center 1995, 2:429-431.
22. Kragg DN, Meijer SJ, Weaver DL, Luggie BW, Harlow SP, Tanabe KK, Laughlin EG, Alex JC: Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995, 130:654-658.
23. Berger D, Ross M: Surgical management of early-stage malignant melanoma. Adv Oncol 1995, 10:17-25.